nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—CYP2C9—Donepezil—Alzheimer's disease	0.177	1	CbGbCtD
Valsartan—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00274	0.00456	CcSEcCtD
Valsartan—Cardiac disorder—Galantamine—Alzheimer's disease	0.00274	0.00456	CcSEcCtD
Valsartan—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00268	0.00446	CcSEcCtD
Valsartan—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00268	0.00446	CcSEcCtD
Valsartan—Angiopathy—Galantamine—Alzheimer's disease	0.00268	0.00445	CcSEcCtD
Valsartan—Immune system disorder—Galantamine—Alzheimer's disease	0.00267	0.00443	CcSEcCtD
Valsartan—Muscular weakness—Memantine—Alzheimer's disease	0.00265	0.0044	CcSEcCtD
Valsartan—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00265	0.0044	CcSEcCtD
Valsartan—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00259	0.00431	CcSEcCtD
Valsartan—Mental disorder—Galantamine—Alzheimer's disease	0.00259	0.0043	CcSEcCtD
Valsartan—Malnutrition—Galantamine—Alzheimer's disease	0.00257	0.00427	CcSEcCtD
Valsartan—Infestation NOS—Donepezil—Alzheimer's disease	0.00255	0.00424	CcSEcCtD
Valsartan—Infestation—Donepezil—Alzheimer's disease	0.00255	0.00424	CcSEcCtD
Valsartan—Flatulence—Galantamine—Alzheimer's disease	0.00253	0.00421	CcSEcCtD
Valsartan—Dysgeusia—Galantamine—Alzheimer's disease	0.00252	0.00419	CcSEcCtD
Valsartan—Irbesartan—PTGS1—Alzheimer's disease	0.00251	0.287	CrCbGaD
Valsartan—Candesartan—PTGS1—Alzheimer's disease	0.00251	0.287	CrCbGaD
Valsartan—Renal failure—Donepezil—Alzheimer's disease	0.00251	0.00417	CcSEcCtD
Valsartan—Bronchitis—Memantine—Alzheimer's disease	0.0025	0.00415	CcSEcCtD
Valsartan—Back pain—Galantamine—Alzheimer's disease	0.00249	0.00413	CcSEcCtD
Valsartan—Muscle spasms—Galantamine—Alzheimer's disease	0.00247	0.00411	CcSEcCtD
Valsartan—Bronchitis—Rivastigmine—Alzheimer's disease	0.00244	0.00406	CcSEcCtD
Valsartan—Neutropenia—Memantine—Alzheimer's disease	0.00243	0.00404	CcSEcCtD
Valsartan—Vision blurred—Galantamine—Alzheimer's disease	0.00242	0.00403	CcSEcCtD
Valsartan—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00241	0.00401	CcSEcCtD
Valsartan—Epistaxis—Donepezil—Alzheimer's disease	0.0024	0.004	CcSEcCtD
Valsartan—Erectile dysfunction—Memantine—Alzheimer's disease	0.00239	0.00398	CcSEcCtD
Valsartan—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00236	0.00392	CcSEcCtD
Valsartan—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00234	0.00389	CcSEcCtD
Valsartan—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00232	0.00385	CcSEcCtD
Valsartan—Infestation NOS—Memantine—Alzheimer's disease	0.00231	0.00385	CcSEcCtD
Valsartan—Infestation—Memantine—Alzheimer's disease	0.00231	0.00385	CcSEcCtD
Valsartan—Vertigo—Galantamine—Alzheimer's disease	0.00231	0.00384	CcSEcCtD
Valsartan—Syncope—Galantamine—Alzheimer's disease	0.0023	0.00383	CcSEcCtD
Valsartan—Haemoglobin—Donepezil—Alzheimer's disease	0.0023	0.00382	CcSEcCtD
Valsartan—Rhinitis—Donepezil—Alzheimer's disease	0.00229	0.00381	CcSEcCtD
Valsartan—Haemorrhage—Donepezil—Alzheimer's disease	0.00229	0.00381	CcSEcCtD
Valsartan—Hepatitis—Donepezil—Alzheimer's disease	0.00229	0.00381	CcSEcCtD
Valsartan—Renal failure—Memantine—Alzheimer's disease	0.00227	0.00378	CcSEcCtD
Valsartan—Palpitations—Galantamine—Alzheimer's disease	0.00227	0.00378	CcSEcCtD
Valsartan—Pharyngitis—Donepezil—Alzheimer's disease	0.00227	0.00378	CcSEcCtD
Valsartan—Infestation—Rivastigmine—Alzheimer's disease	0.00226	0.00376	CcSEcCtD
Valsartan—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00226	0.00376	CcSEcCtD
Valsartan—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00226	0.00376	CcSEcCtD
Valsartan—Loss of consciousness—Galantamine—Alzheimer's disease	0.00226	0.00376	CcSEcCtD
Valsartan—Urethral disorder—Donepezil—Alzheimer's disease	0.00224	0.00373	CcSEcCtD
Valsartan—Cough—Galantamine—Alzheimer's disease	0.00224	0.00373	CcSEcCtD
Valsartan—Renal failure—Rivastigmine—Alzheimer's disease	0.00223	0.0037	CcSEcCtD
Valsartan—Arthralgia—Galantamine—Alzheimer's disease	0.00219	0.00364	CcSEcCtD
Valsartan—Chest pain—Galantamine—Alzheimer's disease	0.00219	0.00364	CcSEcCtD
Valsartan—Myalgia—Galantamine—Alzheimer's disease	0.00219	0.00364	CcSEcCtD
Valsartan—Epistaxis—Memantine—Alzheimer's disease	0.00218	0.00363	CcSEcCtD
Valsartan—Anxiety—Galantamine—Alzheimer's disease	0.00218	0.00363	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00217	0.00361	CcSEcCtD
Valsartan—Sinusitis—Memantine—Alzheimer's disease	0.00217	0.00361	CcSEcCtD
Valsartan—Dry mouth—Galantamine—Alzheimer's disease	0.00214	0.00356	CcSEcCtD
Valsartan—Epistaxis—Rivastigmine—Alzheimer's disease	0.00214	0.00355	CcSEcCtD
Valsartan—Sinusitis—Rivastigmine—Alzheimer's disease	0.00212	0.00353	CcSEcCtD
Valsartan—Haemoglobin—Memantine—Alzheimer's disease	0.00209	0.00347	CcSEcCtD
Valsartan—Rhinitis—Memantine—Alzheimer's disease	0.00208	0.00346	CcSEcCtD
Valsartan—Hepatitis—Memantine—Alzheimer's disease	0.00208	0.00345	CcSEcCtD
Valsartan—Haemorrhage—Memantine—Alzheimer's disease	0.00208	0.00345	CcSEcCtD
Valsartan—Shock—Galantamine—Alzheimer's disease	0.00206	0.00343	CcSEcCtD
Valsartan—Pharyngitis—Memantine—Alzheimer's disease	0.00206	0.00343	CcSEcCtD
Valsartan—Nervous system disorder—Galantamine—Alzheimer's disease	0.00206	0.00342	CcSEcCtD
Valsartan—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00205	0.00342	CcSEcCtD
Valsartan—Urinary tract disorder—Memantine—Alzheimer's disease	0.00205	0.00341	CcSEcCtD
Valsartan—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00204	0.0034	CcSEcCtD
Valsartan—Connective tissue disorder—Memantine—Alzheimer's disease	0.00204	0.00339	CcSEcCtD
Valsartan—Rhinitis—Rivastigmine—Alzheimer's disease	0.00204	0.00339	CcSEcCtD
Valsartan—Skin disorder—Galantamine—Alzheimer's disease	0.00204	0.00339	CcSEcCtD
Valsartan—Urethral disorder—Memantine—Alzheimer's disease	0.00204	0.00339	CcSEcCtD
Valsartan—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00203	0.00338	CcSEcCtD
Valsartan—Hepatitis—Rivastigmine—Alzheimer's disease	0.00203	0.00338	CcSEcCtD
Valsartan—Alopecia—Donepezil—Alzheimer's disease	0.00202	0.00336	CcSEcCtD
Valsartan—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00202	0.00335	CcSEcCtD
Valsartan—Losartan—ACE—Alzheimer's disease	0.00201	0.23	CrCbGaD
Valsartan—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00201	0.00334	CcSEcCtD
Valsartan—Mental disorder—Donepezil—Alzheimer's disease	0.002	0.00333	CcSEcCtD
Valsartan—Anorexia—Galantamine—Alzheimer's disease	0.002	0.00332	CcSEcCtD
Valsartan—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.002	0.00332	CcSEcCtD
Valsartan—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00199	0.00331	CcSEcCtD
Valsartan—Malnutrition—Donepezil—Alzheimer's disease	0.00199	0.00331	CcSEcCtD
Valsartan—Flatulence—Donepezil—Alzheimer's disease	0.00196	0.00326	CcSEcCtD
Valsartan—Hypotension—Galantamine—Alzheimer's disease	0.00196	0.00326	CcSEcCtD
Valsartan—Dysgeusia—Donepezil—Alzheimer's disease	0.00195	0.00324	CcSEcCtD
Valsartan—Cardiac disorder—Memantine—Alzheimer's disease	0.00193	0.00321	CcSEcCtD
Valsartan—Back pain—Donepezil—Alzheimer's disease	0.00193	0.0032	CcSEcCtD
Valsartan—Muscle spasms—Donepezil—Alzheimer's disease	0.00191	0.00318	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00191	0.00318	CcSEcCtD
Valsartan—Insomnia—Galantamine—Alzheimer's disease	0.0019	0.00315	CcSEcCtD
Valsartan—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00189	0.00314	CcSEcCtD
Valsartan—Angiopathy—Memantine—Alzheimer's disease	0.00188	0.00313	CcSEcCtD
Valsartan—Paraesthesia—Galantamine—Alzheimer's disease	0.00188	0.00313	CcSEcCtD
Valsartan—Vision blurred—Donepezil—Alzheimer's disease	0.00188	0.00312	CcSEcCtD
Valsartan—Immune system disorder—Memantine—Alzheimer's disease	0.00188	0.00312	CcSEcCtD
Valsartan—Mediastinal disorder—Memantine—Alzheimer's disease	0.00187	0.00311	CcSEcCtD
Valsartan—Somnolence—Galantamine—Alzheimer's disease	0.00186	0.0031	CcSEcCtD
Valsartan—Dyspepsia—Galantamine—Alzheimer's disease	0.00185	0.00307	CcSEcCtD
Valsartan—Angiopathy—Rivastigmine—Alzheimer's disease	0.00184	0.00307	CcSEcCtD
Valsartan—Alopecia—Memantine—Alzheimer's disease	0.00184	0.00305	CcSEcCtD
Valsartan—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00183	0.00305	CcSEcCtD
Valsartan—Decreased appetite—Galantamine—Alzheimer's disease	0.00182	0.00303	CcSEcCtD
Valsartan—Mental disorder—Memantine—Alzheimer's disease	0.00182	0.00303	CcSEcCtD
Valsartan—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00181	0.00301	CcSEcCtD
Valsartan—Malnutrition—Memantine—Alzheimer's disease	0.00181	0.00301	CcSEcCtD
Valsartan—Fatigue—Galantamine—Alzheimer's disease	0.00181	0.00301	CcSEcCtD
Valsartan—Alopecia—Rivastigmine—Alzheimer's disease	0.0018	0.00299	CcSEcCtD
Valsartan—Constipation—Galantamine—Alzheimer's disease	0.00179	0.00298	CcSEcCtD
Valsartan—Vertigo—Donepezil—Alzheimer's disease	0.00179	0.00298	CcSEcCtD
Valsartan—Syncope—Donepezil—Alzheimer's disease	0.00179	0.00297	CcSEcCtD
Valsartan—Flatulence—Memantine—Alzheimer's disease	0.00178	0.00296	CcSEcCtD
Valsartan—Mental disorder—Rivastigmine—Alzheimer's disease	0.00178	0.00296	CcSEcCtD
Valsartan—Dysgeusia—Memantine—Alzheimer's disease	0.00177	0.00295	CcSEcCtD
Valsartan—Malnutrition—Rivastigmine—Alzheimer's disease	0.00177	0.00294	CcSEcCtD
Valsartan—Loss of consciousness—Donepezil—Alzheimer's disease	0.00175	0.00291	CcSEcCtD
Valsartan—Back pain—Memantine—Alzheimer's disease	0.00175	0.00291	CcSEcCtD
Valsartan—Flatulence—Rivastigmine—Alzheimer's disease	0.00174	0.0029	CcSEcCtD
Valsartan—Cough—Donepezil—Alzheimer's disease	0.00174	0.00289	CcSEcCtD
Valsartan—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00173	0.00288	CcSEcCtD
Valsartan—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00172	0.00285	CcSEcCtD
Valsartan—Back pain—Rivastigmine—Alzheimer's disease	0.00171	0.00285	CcSEcCtD
Valsartan—Irbesartan—CYP2D6—Alzheimer's disease	0.00171	0.195	CrCbGaD
Valsartan—Vision blurred—Memantine—Alzheimer's disease	0.0017	0.00283	CcSEcCtD
Valsartan—Muscle spasms—Rivastigmine—Alzheimer's disease	0.0017	0.00283	CcSEcCtD
Valsartan—Arthralgia—Donepezil—Alzheimer's disease	0.0017	0.00282	CcSEcCtD
Valsartan—Chest pain—Donepezil—Alzheimer's disease	0.0017	0.00282	CcSEcCtD
Valsartan—Myalgia—Donepezil—Alzheimer's disease	0.0017	0.00282	CcSEcCtD
Valsartan—Anxiety—Donepezil—Alzheimer's disease	0.00169	0.00281	CcSEcCtD
Valsartan—Vision blurred—Rivastigmine—Alzheimer's disease	0.00167	0.00277	CcSEcCtD
Valsartan—Dry mouth—Donepezil—Alzheimer's disease	0.00166	0.00276	CcSEcCtD
Valsartan—Abdominal pain—Galantamine—Alzheimer's disease	0.00166	0.00276	CcSEcCtD
Valsartan—Oedema—Donepezil—Alzheimer's disease	0.00163	0.0027	CcSEcCtD
Valsartan—Vertigo—Memantine—Alzheimer's disease	0.00162	0.0027	CcSEcCtD
Valsartan—Syncope—Memantine—Alzheimer's disease	0.00162	0.0027	CcSEcCtD
Valsartan—Infection—Donepezil—Alzheimer's disease	0.00161	0.00269	CcSEcCtD
Valsartan—Shock—Donepezil—Alzheimer's disease	0.0016	0.00266	CcSEcCtD
Valsartan—Palpitations—Memantine—Alzheimer's disease	0.0016	0.00266	CcSEcCtD
Valsartan—Nervous system disorder—Donepezil—Alzheimer's disease	0.00159	0.00265	CcSEcCtD
Valsartan—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00159	0.00265	CcSEcCtD
Valsartan—Vertigo—Rivastigmine—Alzheimer's disease	0.00159	0.00264	CcSEcCtD
Valsartan—Loss of consciousness—Memantine—Alzheimer's disease	0.00159	0.00264	CcSEcCtD
Valsartan—Syncope—Rivastigmine—Alzheimer's disease	0.00159	0.00264	CcSEcCtD
Valsartan—Cough—Memantine—Alzheimer's disease	0.00158	0.00262	CcSEcCtD
Valsartan—Palpitations—Rivastigmine—Alzheimer's disease	0.00156	0.0026	CcSEcCtD
Valsartan—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00155	0.00259	CcSEcCtD
Valsartan—Anorexia—Donepezil—Alzheimer's disease	0.00155	0.00258	CcSEcCtD
Valsartan—Hypersensitivity—Galantamine—Alzheimer's disease	0.00155	0.00257	CcSEcCtD
Valsartan—Cough—Rivastigmine—Alzheimer's disease	0.00154	0.00257	CcSEcCtD
Valsartan—Arthralgia—Memantine—Alzheimer's disease	0.00154	0.00256	CcSEcCtD
Valsartan—Chest pain—Memantine—Alzheimer's disease	0.00154	0.00256	CcSEcCtD
Valsartan—Myalgia—Memantine—Alzheimer's disease	0.00154	0.00256	CcSEcCtD
Valsartan—Anxiety—Memantine—Alzheimer's disease	0.00153	0.00255	CcSEcCtD
Valsartan—Hypotension—Donepezil—Alzheimer's disease	0.00152	0.00253	CcSEcCtD
Valsartan—Arthralgia—Rivastigmine—Alzheimer's disease	0.00151	0.0025	CcSEcCtD
Valsartan—Chest pain—Rivastigmine—Alzheimer's disease	0.00151	0.0025	CcSEcCtD
Valsartan—Myalgia—Rivastigmine—Alzheimer's disease	0.00151	0.0025	CcSEcCtD
Valsartan—Dry mouth—Memantine—Alzheimer's disease	0.00151	0.0025	CcSEcCtD
Valsartan—Asthenia—Galantamine—Alzheimer's disease	0.0015	0.0025	CcSEcCtD
Valsartan—Anxiety—Rivastigmine—Alzheimer's disease	0.0015	0.0025	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.0015	0.00249	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00148	0.00246	CcSEcCtD
Valsartan—Oedema—Memantine—Alzheimer's disease	0.00148	0.00245	CcSEcCtD
Valsartan—Dry mouth—Rivastigmine—Alzheimer's disease	0.00147	0.00245	CcSEcCtD
Valsartan—Insomnia—Donepezil—Alzheimer's disease	0.00147	0.00245	CcSEcCtD
Valsartan—Infection—Memantine—Alzheimer's disease	0.00147	0.00244	CcSEcCtD
Valsartan—Paraesthesia—Donepezil—Alzheimer's disease	0.00146	0.00243	CcSEcCtD
Valsartan—Shock—Memantine—Alzheimer's disease	0.00145	0.00241	CcSEcCtD
Valsartan—Dyspnoea—Donepezil—Alzheimer's disease	0.00145	0.00241	CcSEcCtD
Valsartan—Nervous system disorder—Memantine—Alzheimer's disease	0.00145	0.00241	CcSEcCtD
Valsartan—Somnolence—Donepezil—Alzheimer's disease	0.00145	0.0024	CcSEcCtD
Valsartan—Thrombocytopenia—Memantine—Alzheimer's disease	0.00145	0.0024	CcSEcCtD
Valsartan—Oedema—Rivastigmine—Alzheimer's disease	0.00144	0.0024	CcSEcCtD
Valsartan—Diarrhoea—Galantamine—Alzheimer's disease	0.00144	0.00239	CcSEcCtD
Valsartan—Infection—Rivastigmine—Alzheimer's disease	0.00143	0.00239	CcSEcCtD
Valsartan—Skin disorder—Memantine—Alzheimer's disease	0.00143	0.00238	CcSEcCtD
Valsartan—Dyspepsia—Donepezil—Alzheimer's disease	0.00143	0.00238	CcSEcCtD
Valsartan—Shock—Rivastigmine—Alzheimer's disease	0.00142	0.00236	CcSEcCtD
Valsartan—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00142	0.00235	CcSEcCtD
Valsartan—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00141	0.00235	CcSEcCtD
Valsartan—Decreased appetite—Donepezil—Alzheimer's disease	0.00141	0.00235	CcSEcCtD
Valsartan—Anorexia—Memantine—Alzheimer's disease	0.00141	0.00234	CcSEcCtD
Valsartan—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0014	0.00233	CcSEcCtD
Valsartan—Skin disorder—Rivastigmine—Alzheimer's disease	0.0014	0.00233	CcSEcCtD
Valsartan—Fatigue—Donepezil—Alzheimer's disease	0.0014	0.00233	CcSEcCtD
Valsartan—Constipation—Donepezil—Alzheimer's disease	0.00139	0.00231	CcSEcCtD
Valsartan—Dizziness—Galantamine—Alzheimer's disease	0.00139	0.00231	CcSEcCtD
Valsartan—Hypotension—Memantine—Alzheimer's disease	0.00138	0.00229	CcSEcCtD
Valsartan—Anorexia—Rivastigmine—Alzheimer's disease	0.00138	0.00229	CcSEcCtD
Valsartan—Hypotension—Rivastigmine—Alzheimer's disease	0.00135	0.00224	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00134	0.00224	CcSEcCtD
Valsartan—Insomnia—Memantine—Alzheimer's disease	0.00133	0.00222	CcSEcCtD
Valsartan—Vomiting—Galantamine—Alzheimer's disease	0.00133	0.00222	CcSEcCtD
Valsartan—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00133	0.00221	CcSEcCtD
Valsartan—Paraesthesia—Memantine—Alzheimer's disease	0.00133	0.0022	CcSEcCtD
Valsartan—Rash—Galantamine—Alzheimer's disease	0.00132	0.0022	CcSEcCtD
Valsartan—Dermatitis—Galantamine—Alzheimer's disease	0.00132	0.0022	CcSEcCtD
Valsartan—Dyspnoea—Memantine—Alzheimer's disease	0.00132	0.00219	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00132	0.00219	CcSEcCtD
Valsartan—Headache—Galantamine—Alzheimer's disease	0.00131	0.00219	CcSEcCtD
Valsartan—Somnolence—Memantine—Alzheimer's disease	0.00131	0.00218	CcSEcCtD
Valsartan—Insomnia—Rivastigmine—Alzheimer's disease	0.00131	0.00217	CcSEcCtD
Valsartan—Dyspepsia—Memantine—Alzheimer's disease	0.0013	0.00216	CcSEcCtD
Valsartan—Paraesthesia—Rivastigmine—Alzheimer's disease	0.0013	0.00216	CcSEcCtD
Valsartan—Urticaria—Donepezil—Alzheimer's disease	0.00129	0.00215	CcSEcCtD
Valsartan—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00129	0.00214	CcSEcCtD
Valsartan—Abdominal pain—Donepezil—Alzheimer's disease	0.00129	0.00214	CcSEcCtD
Valsartan—Somnolence—Rivastigmine—Alzheimer's disease	0.00128	0.00213	CcSEcCtD
Valsartan—Decreased appetite—Memantine—Alzheimer's disease	0.00128	0.00213	CcSEcCtD
Valsartan—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00127	0.00212	CcSEcCtD
Valsartan—Fatigue—Memantine—Alzheimer's disease	0.00127	0.00212	CcSEcCtD
Valsartan—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00127	0.00211	CcSEcCtD
Valsartan—Constipation—Memantine—Alzheimer's disease	0.00126	0.0021	CcSEcCtD
Valsartan—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00126	0.00209	CcSEcCtD
Valsartan—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00125	0.00207	CcSEcCtD
Valsartan—Nausea—Galantamine—Alzheimer's disease	0.00125	0.00207	CcSEcCtD
Valsartan—Fatigue—Rivastigmine—Alzheimer's disease	0.00124	0.00207	CcSEcCtD
Valsartan—Constipation—Rivastigmine—Alzheimer's disease	0.00123	0.00205	CcSEcCtD
Valsartan—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00121	0.00201	CcSEcCtD
Valsartan—Hypersensitivity—Donepezil—Alzheimer's disease	0.0012	0.00199	CcSEcCtD
Valsartan—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00118	0.00196	CcSEcCtD
Valsartan—Urticaria—Memantine—Alzheimer's disease	0.00117	0.00195	CcSEcCtD
Valsartan—Abdominal pain—Memantine—Alzheimer's disease	0.00117	0.00194	CcSEcCtD
Valsartan—Asthenia—Donepezil—Alzheimer's disease	0.00117	0.00194	CcSEcCtD
Valsartan—Pruritus—Donepezil—Alzheimer's disease	0.00115	0.00191	CcSEcCtD
Valsartan—Urticaria—Rivastigmine—Alzheimer's disease	0.00115	0.00191	CcSEcCtD
Valsartan—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00114	0.0019	CcSEcCtD
Valsartan—Diarrhoea—Donepezil—Alzheimer's disease	0.00111	0.00185	CcSEcCtD
Valsartan—Hypersensitivity—Memantine—Alzheimer's disease	0.00109	0.00181	CcSEcCtD
Valsartan—Dizziness—Donepezil—Alzheimer's disease	0.00107	0.00179	CcSEcCtD
Valsartan—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00106	0.00177	CcSEcCtD
Valsartan—Asthenia—Memantine—Alzheimer's disease	0.00106	0.00176	CcSEcCtD
Valsartan—Pruritus—Memantine—Alzheimer's disease	0.00104	0.00174	CcSEcCtD
Valsartan—Asthenia—Rivastigmine—Alzheimer's disease	0.00104	0.00172	CcSEcCtD
Valsartan—Vomiting—Donepezil—Alzheimer's disease	0.00103	0.00172	CcSEcCtD
Valsartan—Rash—Donepezil—Alzheimer's disease	0.00102	0.0017	CcSEcCtD
Valsartan—Dermatitis—Donepezil—Alzheimer's disease	0.00102	0.0017	CcSEcCtD
Valsartan—Pruritus—Rivastigmine—Alzheimer's disease	0.00102	0.0017	CcSEcCtD
Valsartan—Headache—Donepezil—Alzheimer's disease	0.00102	0.00169	CcSEcCtD
Valsartan—Diarrhoea—Memantine—Alzheimer's disease	0.00101	0.00168	CcSEcCtD
Valsartan—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000988	0.00164	CcSEcCtD
Valsartan—Dizziness—Memantine—Alzheimer's disease	0.000976	0.00162	CcSEcCtD
Valsartan—Nausea—Donepezil—Alzheimer's disease	0.000966	0.00161	CcSEcCtD
Valsartan—Dizziness—Rivastigmine—Alzheimer's disease	0.000955	0.00159	CcSEcCtD
Valsartan—Vomiting—Memantine—Alzheimer's disease	0.000938	0.00156	CcSEcCtD
Valsartan—Rash—Memantine—Alzheimer's disease	0.000931	0.00155	CcSEcCtD
Valsartan—Dermatitis—Memantine—Alzheimer's disease	0.00093	0.00155	CcSEcCtD
Valsartan—Headache—Memantine—Alzheimer's disease	0.000925	0.00154	CcSEcCtD
Valsartan—Vomiting—Rivastigmine—Alzheimer's disease	0.000918	0.00153	CcSEcCtD
Valsartan—Rash—Rivastigmine—Alzheimer's disease	0.00091	0.00151	CcSEcCtD
Valsartan—Dermatitis—Rivastigmine—Alzheimer's disease	0.00091	0.00151	CcSEcCtD
Valsartan—Headache—Rivastigmine—Alzheimer's disease	0.000905	0.0015	CcSEcCtD
Valsartan—Nausea—Memantine—Alzheimer's disease	0.000877	0.00146	CcSEcCtD
Valsartan—Nausea—Rivastigmine—Alzheimer's disease	0.000858	0.00143	CcSEcCtD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000163	0.000763	CbGpPWpGaD
Valsartan—ALB—Metabolism—DHCR24—Alzheimer's disease	0.000161	0.000756	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GAPDH—Alzheimer's disease	0.000161	0.000755	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000159	0.000747	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—VEGFA—Alzheimer's disease	0.000158	0.000743	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—Alzheimer's disease	0.000158	0.000743	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000158	0.00074	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL6—Alzheimer's disease	0.000157	0.000737	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—A2M—Alzheimer's disease	0.000155	0.000729	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	0.000151	0.000709	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Alzheimer's disease	0.000151	0.000708	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.00015	0.000705	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—A2M—Alzheimer's disease	0.000149	0.000699	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000148	0.000696	CbGpPWpGaD
Valsartan—ALB—Hemostasis—A2M—Alzheimer's disease	0.000147	0.000691	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000147	0.000689	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—TGFB1—Alzheimer's disease	0.000145	0.000682	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PSEN2—Alzheimer's disease	0.000144	0.000677	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.00014	0.000657	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TP53—Alzheimer's disease	0.00014	0.000655	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000139	0.000653	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000139	0.00065	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—Alzheimer's disease	0.000139	0.00065	CbGpPWpGaD
Valsartan—ALB—Metabolism—CA4—Alzheimer's disease	0.000137	0.000643	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000136	0.000639	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ACHE—Alzheimer's disease	0.000135	0.000635	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000134	0.000629	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—INPP5D—Alzheimer's disease	0.000134	0.000627	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000133	0.000626	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPY—Alzheimer's disease	0.000133	0.000623	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000133	0.000622	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	0.000132	0.000619	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IAPP—Alzheimer's disease	0.000132	0.000619	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	0.000131	0.000613	CbGpPWpGaD
Valsartan—ALB—Metabolism—GAPDHS—Alzheimer's disease	0.000129	0.000605	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CRH—Alzheimer's disease	0.000128	0.000601	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—Alzheimer's disease	0.000128	0.0006	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000128	0.000598	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000127	0.000598	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ENO1—Alzheimer's disease	0.000127	0.000595	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS1—Alzheimer's disease	0.000127	0.000595	CbGpPWpGaD
Valsartan—ALB—Hemostasis—INPP5D—Alzheimer's disease	0.000127	0.000594	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCR5—Alzheimer's disease	0.000126	0.000593	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—Alzheimer's disease	0.000126	0.00059	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TF—Alzheimer's disease	0.000125	0.000587	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP2D6—Alzheimer's disease	0.000124	0.000583	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000124	0.00058	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000123	0.000577	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	0.000123	0.000576	CbGpPWpGaD
Valsartan—ALB—Metabolism—ATP5A1—Alzheimer's disease	0.000122	0.000573	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPS—Alzheimer's disease	0.000121	0.00057	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000121	0.000567	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—F2—Alzheimer's disease	0.000119	0.00056	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PTK2B—Alzheimer's disease	0.000119	0.000559	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—BCHE—Alzheimer's disease	0.000118	0.000553	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TPI1—Alzheimer's disease	0.000117	0.00055	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CHAT—Alzheimer's disease	0.000117	0.00055	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLD3—Alzheimer's disease	0.000117	0.000547	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000117	0.000547	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NTRK2—Alzheimer's disease	0.000116	0.000544	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GAB2—Alzheimer's disease	0.000116	0.000544	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SST—Alzheimer's disease	0.000116	0.000544	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CALM1—Alzheimer's disease	0.000115	0.000541	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000115	0.000541	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GSK3A—Alzheimer's disease	0.000115	0.000539	CbGpPWpGaD
Valsartan—ALB—Hemostasis—GAB2—Alzheimer's disease	0.000114	0.000537	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APP—Alzheimer's disease	0.000113	0.00053	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOB—Alzheimer's disease	0.000112	0.000527	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CA4—Alzheimer's disease	0.000112	0.000527	CbGpPWpGaD
Valsartan—ALB—Metabolism—HSD17B10—Alzheimer's disease	0.000112	0.000524	CbGpPWpGaD
Valsartan—ALB—Hemostasis—APP—Alzheimer's disease	0.000112	0.000523	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PLCB1—Alzheimer's disease	0.000111	0.000522	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.00011	0.000515	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000109	0.000513	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000109	0.000512	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—F2—Alzheimer's disease	0.000108	0.000509	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000108	0.000508	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GAPDH—Alzheimer's disease	0.000108	0.000507	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCA1—Alzheimer's disease	0.000108	0.000506	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP46A1—Alzheimer's disease	0.000108	0.000505	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.000108	0.000505	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000107	0.000502	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PLCB1—Alzheimer's disease	0.000107	0.0005	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000106	0.000497	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	0.000106	0.000495	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—A2M—Alzheimer's disease	0.000104	0.00049	CbGpPWpGaD
Valsartan—ALB—Metabolism—ND1—Alzheimer's disease	0.000104	0.000487	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000102	0.000476	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	0.000102	0.000476	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	0.0001	0.000469	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NGFR—Alzheimer's disease	9.94e-05	0.000466	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CREB1—Alzheimer's disease	9.88e-05	0.000463	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADAM10—Alzheimer's disease	9.71e-05	0.000455	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CCL2—Alzheimer's disease	9.66e-05	0.000453	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLD3—Alzheimer's disease	9.54e-05	0.000448	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	9.54e-05	0.000448	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	9.43e-05	0.000443	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.31e-05	0.000437	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	9.29e-05	0.000436	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPARGC1A—Alzheimer's disease	9.29e-05	0.000436	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—HMOX1—Alzheimer's disease	9.25e-05	0.000434	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—S100B—Alzheimer's disease	9.18e-05	0.000431	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	9.15e-05	0.000429	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SOD1—Alzheimer's disease	9.09e-05	0.000427	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ACHE—Alzheimer's disease	9.09e-05	0.000426	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—INPP5D—Alzheimer's disease	8.98e-05	0.000421	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	8.94e-05	0.000419	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	8.81e-05	0.000413	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF2—Alzheimer's disease	8.74e-05	0.00041	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF2—Alzheimer's disease	8.64e-05	0.000405	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS1—Alzheimer's disease	8.52e-05	0.000399	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ENO1—Alzheimer's disease	8.52e-05	0.000399	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ND1—Alzheimer's disease	8.51e-05	0.000399	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—LPL—Alzheimer's disease	8.46e-05	0.000397	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF1R—Alzheimer's disease	8.45e-05	0.000397	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2D6—Alzheimer's disease	8.35e-05	0.000392	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	8.31e-05	0.00039	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LPL—Alzheimer's disease	8.1e-05	0.00038	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MEF2C—Alzheimer's disease	8.03e-05	0.000377	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	8.01e-05	0.000376	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—BCHE—Alzheimer's disease	7.92e-05	0.000371	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PRKCG—Alzheimer's disease	7.88e-05	0.00037	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PRKCG—Alzheimer's disease	7.78e-05	0.000365	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NGF—Alzheimer's disease	7.68e-05	0.00036	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—Alzheimer's disease	7.61e-05	0.000357	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	7.6e-05	0.000357	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	7.58e-05	0.000355	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLCB1—Alzheimer's disease	7.47e-05	0.00035	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR5—Alzheimer's disease	7.47e-05	0.00035	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.33e-05	0.000344	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2A—Alzheimer's disease	7.31e-05	0.000343	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	7.29e-05	0.000342	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCA1—Alzheimer's disease	7.24e-05	0.00034	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CALM1—Alzheimer's disease	7.11e-05	0.000334	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOE—Alzheimer's disease	7.09e-05	0.000333	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	7.03e-05	0.00033	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CAV1—Alzheimer's disease	7.02e-05	0.000329	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CALM1—Alzheimer's disease	6.82e-05	0.00032	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLAU—Alzheimer's disease	6.81e-05	0.000319	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—LEP—Alzheimer's disease	6.79e-05	0.000319	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOE—Alzheimer's disease	6.79e-05	0.000319	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CALM1—Alzheimer's disease	6.73e-05	0.000316	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CAV1—Alzheimer's disease	6.73e-05	0.000316	CbGpPWpGaD
Valsartan—ALB—Metabolism—TPI1—Alzheimer's disease	6.7e-05	0.000314	CbGpPWpGaD
Valsartan—ALB—Metabolism—CHAT—Alzheimer's disease	6.7e-05	0.000314	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CAV1—Alzheimer's disease	6.65e-05	0.000312	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	6.55e-05	0.000307	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ESR1—Alzheimer's disease	6.49e-05	0.000304	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	6.45e-05	0.000303	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOB—Alzheimer's disease	6.42e-05	0.000301	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—F2—Alzheimer's disease	6.41e-05	0.000301	CbGpPWpGaD
Valsartan—ALB—Hemostasis—F2—Alzheimer's disease	6.33e-05	0.000297	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.27e-05	0.000294	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS2—Alzheimer's disease	6.25e-05	0.000293	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARGC1A—Alzheimer's disease	6.24e-05	0.000293	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HMOX1—Alzheimer's disease	6.21e-05	0.000291	CbGpPWpGaD
Valsartan—ALB—Metabolism—GAPDH—Alzheimer's disease	6.18e-05	0.00029	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPARG—Alzheimer's disease	6.17e-05	0.00029	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.11e-05	0.000287	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—INS—Alzheimer's disease	6.06e-05	0.000284	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.05e-05	0.000284	CbGpPWpGaD
Valsartan—ALB—Metabolism—A2M—Alzheimer's disease	5.97e-05	0.00028	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	5.97e-05	0.00028	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GSK3B—Alzheimer's disease	5.88e-05	0.000276	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CREB1—Alzheimer's disease	5.84e-05	0.000274	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—INS—Alzheimer's disease	5.8e-05	0.000272	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL2—Alzheimer's disease	5.71e-05	0.000268	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—LPL—Alzheimer's disease	5.68e-05	0.000267	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IGF1—Alzheimer's disease	5.61e-05	0.000263	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IGF1—Alzheimer's disease	5.55e-05	0.00026	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TPI1—Alzheimer's disease	5.48e-05	0.000257	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CHAT—Alzheimer's disease	5.48e-05	0.000257	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.32e-05	0.00025	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NOS3—Alzheimer's disease	5.31e-05	0.000249	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOB—Alzheimer's disease	5.25e-05	0.000247	CbGpPWpGaD
Valsartan—ALB—Metabolism—ACHE—Alzheimer's disease	5.19e-05	0.000244	CbGpPWpGaD
Valsartan—ALB—Metabolism—INPP5D—Alzheimer's disease	5.13e-05	0.000241	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—Alzheimer's disease	5.12e-05	0.00024	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOS3—Alzheimer's disease	5.09e-05	0.000239	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	5.06e-05	0.000237	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS3—Alzheimer's disease	5.03e-05	0.000236	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5e-05	0.000235	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.96e-05	0.000232	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—A2M—Alzheimer's disease	4.89e-05	0.000229	CbGpPWpGaD
Valsartan—ALB—Metabolism—ENO1—Alzheimer's disease	4.87e-05	0.000228	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS1—Alzheimer's disease	4.87e-05	0.000228	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—Alzheimer's disease	4.86e-05	0.000228	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CALM1—Alzheimer's disease	4.78e-05	0.000224	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2D6—Alzheimer's disease	4.77e-05	0.000224	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOE—Alzheimer's disease	4.76e-05	0.000223	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAV1—Alzheimer's disease	4.72e-05	0.000221	CbGpPWpGaD
Valsartan—ALB—Metabolism—BCHE—Alzheimer's disease	4.52e-05	0.000212	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	4.48e-05	0.00021	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.36e-05	0.000205	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.36e-05	0.000204	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CASP3—Alzheimer's disease	4.32e-05	0.000203	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—Alzheimer's disease	4.29e-05	0.000201	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLCB1—Alzheimer's disease	4.27e-05	0.0002	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ACHE—Alzheimer's disease	4.25e-05	0.000199	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	4.2e-05	0.000197	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.19e-05	0.000196	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARG—Alzheimer's disease	4.15e-05	0.000195	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCA1—Alzheimer's disease	4.14e-05	0.000194	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—INS—Alzheimer's disease	4.07e-05	0.000191	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ENO1—Alzheimer's disease	3.98e-05	0.000187	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	3.98e-05	0.000187	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK8—Alzheimer's disease	3.97e-05	0.000186	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—AKT1—Alzheimer's disease	3.96e-05	0.000186	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	3.91e-05	0.000183	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—BCHE—Alzheimer's disease	3.7e-05	0.000174	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—VEGFA—Alzheimer's disease	3.67e-05	0.000172	CbGpPWpGaD
Valsartan—ALB—Hemostasis—VEGFA—Alzheimer's disease	3.62e-05	0.00017	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NOS3—Alzheimer's disease	3.57e-05	0.000167	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARGC1A—Alzheimer's disease	3.57e-05	0.000167	CbGpPWpGaD
Valsartan—ALB—Metabolism—HMOX1—Alzheimer's disease	3.55e-05	0.000167	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	3.49e-05	0.000164	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.43e-05	0.000161	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	3.39e-05	0.000159	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TGFB1—Alzheimer's disease	3.36e-05	0.000158	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TGFB1—Alzheimer's disease	3.32e-05	0.000156	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—Alzheimer's disease	3.26e-05	0.000153	CbGpPWpGaD
Valsartan—ALB—Metabolism—LPL—Alzheimer's disease	3.25e-05	0.000152	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—Alzheimer's disease	2.92e-05	0.000137	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.92e-05	0.000137	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.91e-05	0.000136	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TP53—Alzheimer's disease	2.77e-05	0.00013	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TP53—Alzheimer's disease	2.74e-05	0.000128	CbGpPWpGaD
Valsartan—ALB—Metabolism—CALM1—Alzheimer's disease	2.73e-05	0.000128	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOE—Alzheimer's disease	2.72e-05	0.000128	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAV1—Alzheimer's disease	2.7e-05	0.000126	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.66e-05	0.000125	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—Alzheimer's disease	2.54e-05	0.000119	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—AKT1—Alzheimer's disease	2.44e-05	0.000115	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.39e-05	0.000112	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARG—Alzheimer's disease	2.37e-05	0.000111	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AKT1—Alzheimer's disease	2.34e-05	0.00011	CbGpPWpGaD
Valsartan—ALB—Metabolism—INS—Alzheimer's disease	2.32e-05	0.000109	CbGpPWpGaD
Valsartan—ALB—Hemostasis—AKT1—Alzheimer's disease	2.31e-05	0.000108	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.24e-05	0.000105	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.23e-05	0.000104	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.21e-05	0.000104	CbGpPWpGaD
Valsartan—ALB—Metabolism—NOS3—Alzheimer's disease	2.04e-05	9.56e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.94e-05	9.1e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—INS—Alzheimer's disease	1.9e-05	8.93e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—Alzheimer's disease	1.86e-05	8.75e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.67e-05	7.83e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—AKT1—Alzheimer's disease	1.64e-05	7.69e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.53e-05	7.16e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—AKT1—Alzheimer's disease	9.37e-06	4.4e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AKT1—Alzheimer's disease	7.67e-06	3.6e-05	CbGpPWpGaD
